Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer

Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer

Abstract Background Pharmaceutical companies in Africa need to invest in both facilities and quality management systems to achieve good manufacturing practice (GMP) compliance. Compliance to international GMP standards is important to the attainment of World Health Organization (WHO) prequalificatio...

Full description

Bibliographic Details
Main Authors: Chimezie Anyakora, Obinna Ekwunife, Faith Alozie, Mopa Esuga, Jonathan Ukwuru, Steve Onya, Jude Nwokike
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Health Services Research
Subjects:
Africa
Cost-benefit analysis
Good manufacturing practice
Nigeria
Pharmaceutical companies
Prequalification
Online Access:http://link.springer.com/article/10.1186/s12913-017-2610-8

Internet

http://link.springer.com/article/10.1186/s12913-017-2610-8

Similar Items